HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Understanding why response variability occurs during midlife helps explain why these dosing discussions sometimes arise
Portrait gives you access to great prices from a national supplier network covering peptides, wellness, injectables, GLP-1s, IV/IM supplies, skincare, and more
They overlap only at the GLP-1 receptor and add different second pathways, so they are not the same class and not interchangeable
Market analysis reveals that the off-label prescribing boom generated billions in additional revenue for manufacturer Novo Nordisk, even as reports of serious adverse events began accumulating and lawsuits claim the company prioritized profits over patient safety